Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.23.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 1,192,633 $ 1,595,839
General and administrative 1,085,049 1,190,313
Total operating expenses 2,277,682 2,786,152
Loss from operations (2,277,682) (2,786,152)
Other income and expenses:    
Interest income, net 37,540 0
Net loss $ (2,240,142) $ (2,786,152)
Net loss per share of common stock, basic and diluted $ (2.27) $ (5.35)
Weighted-average basic and diluted common shares 985,848 520,539